Name | Number of supported studies | Average coverage | |
---|---|---|---|
hepatocyte | 5 studies | 78% ± 12% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
liver | 3 studies | 48% ± 11% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
liver | 100% | 44353.05 | 226 / 226 | 98% | 1333.27 | 397 / 406 |
stomach | 93% | 24.35 | 334 / 359 | 24% | 1.81 | 70 / 286 |
intestine | 80% | 20.14 | 770 / 966 | 20% | 3.05 | 108 / 527 |
bladder | 81% | 23.10 | 17 / 21 | 10% | 0.48 | 49 / 504 |
blood vessel | 84% | 20.80 | 1127 / 1335 | 0% | 0 | 0 / 0 |
kidney | 49% | 9.62 | 44 / 89 | 26% | 4.23 | 238 / 901 |
brain | 73% | 23.13 | 1930 / 2642 | 1% | 0.01 | 5 / 705 |
esophagus | 66% | 10.86 | 949 / 1445 | 7% | 0.83 | 13 / 183 |
prostate | 69% | 10.46 | 169 / 245 | 2% | 0.05 | 12 / 502 |
ovary | 62% | 12.12 | 111 / 180 | 1% | 0.10 | 3 / 430 |
uterus | 55% | 6.78 | 94 / 170 | 5% | 0.34 | 25 / 459 |
spleen | 53% | 79.05 | 127 / 241 | 0% | 0 | 0 / 0 |
heart | 50% | 6.33 | 434 / 861 | 0% | 0 | 0 / 0 |
pancreas | 30% | 3.25 | 99 / 328 | 15% | 1.46 | 27 / 178 |
peripheral blood | 43% | 13.27 | 400 / 929 | 0% | 0 | 0 / 0 |
lung | 30% | 2.87 | 174 / 578 | 9% | 1.52 | 100 / 1155 |
adrenal gland | 33% | 3.93 | 85 / 258 | 2% | 0.61 | 4 / 230 |
thymus | 28% | 3.00 | 180 / 653 | 1% | 0.03 | 7 / 605 |
breast | 28% | 4.80 | 128 / 459 | 1% | 0.27 | 9 / 1118 |
adipose | 28% | 9.20 | 335 / 1204 | 0% | 0 | 0 / 0 |
muscle | 27% | 2.55 | 213 / 803 | 0% | 0 | 0 / 0 |
skin | 19% | 2.78 | 344 / 1809 | 4% | 0.16 | 19 / 472 |
tonsil | 0% | 0 | 0 / 0 | 4% | 0.08 | 2 / 45 |
lymph node | 0% | 0 | 0 / 0 | 3% | 0.05 | 1 / 29 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0051480 | Biological process | regulation of cytosolic calcium ion concentration |
GO_0010544 | Biological process | negative regulation of platelet activation |
GO_0006953 | Biological process | acute-phase response |
GO_0030307 | Biological process | positive regulation of cell growth |
GO_0051918 | Biological process | negative regulation of fibrinolysis |
GO_0070945 | Biological process | neutrophil-mediated killing of gram-negative bacterium |
GO_1990806 | Biological process | ligand-gated ion channel signaling pathway |
GO_1900016 | Biological process | negative regulation of cytokine production involved in inflammatory response |
GO_0001934 | Biological process | positive regulation of protein phosphorylation |
GO_0007596 | Biological process | blood coagulation |
GO_0048712 | Biological process | negative regulation of astrocyte differentiation |
GO_0051838 | Biological process | cytolysis by host of symbiont cells |
GO_0042730 | Biological process | fibrinolysis |
GO_0032024 | Biological process | positive regulation of insulin secretion |
GO_0030168 | Biological process | platelet activation |
GO_0030193 | Biological process | regulation of blood coagulation |
GO_0007186 | Biological process | G protein-coupled receptor signaling pathway |
GO_0045861 | Biological process | negative regulation of proteolysis |
GO_0032967 | Biological process | positive regulation of collagen biosynthetic process |
GO_2000379 | Biological process | positive regulation of reactive oxygen species metabolic process |
GO_0006508 | Biological process | proteolysis |
GO_0030194 | Biological process | positive regulation of blood coagulation |
GO_0051281 | Biological process | positive regulation of release of sequestered calcium ion into cytosol |
GO_0051897 | Biological process | positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction |
GO_0008284 | Biological process | positive regulation of cell population proliferation |
GO_0061844 | Biological process | antimicrobial humoral immune response mediated by antimicrobial peptide |
GO_0008360 | Biological process | regulation of cell shape |
GO_1900738 | Biological process | positive regulation of phospholipase C-activating G protein-coupled receptor signaling pathway |
GO_0009611 | Biological process | response to wounding |
GO_0046427 | Biological process | positive regulation of receptor signaling pathway via JAK-STAT |
GO_0090218 | Biological process | positive regulation of lipid kinase activity |
GO_1900182 | Biological process | positive regulation of protein localization to nucleus |
GO_0007166 | Biological process | cell surface receptor signaling pathway |
GO_0005615 | Cellular component | extracellular space |
GO_0009897 | Cellular component | external side of plasma membrane |
GO_0005576 | Cellular component | extracellular region |
GO_0005886 | Cellular component | plasma membrane |
GO_0005796 | Cellular component | Golgi lumen |
GO_0070062 | Cellular component | extracellular exosome |
GO_0062023 | Cellular component | collagen-containing extracellular matrix |
GO_0072562 | Cellular component | blood microparticle |
GO_0005788 | Cellular component | endoplasmic reticulum lumen |
GO_0008201 | Molecular function | heparin binding |
GO_0070053 | Molecular function | thrombospondin receptor activity |
GO_0005102 | Molecular function | signaling receptor binding |
GO_0008083 | Molecular function | growth factor activity |
GO_0001530 | Molecular function | lipopolysaccharide binding |
GO_0005509 | Molecular function | calcium ion binding |
GO_0005515 | Molecular function | protein binding |
GO_0004252 | Molecular function | serine-type endopeptidase activity |
Gene name | F2 |
Protein name | Prothrombin (EC 3.4.21.5) (Coagulation factor II) [Cleaved into: Activation peptide fragment 1; Activation peptide fragment 2; Thrombin light chain; Thrombin heavy chain] Thrombin factor II F2 protein Prothrombin Plasminogen (EC 3.4.21.7) Prothrombin (EC 3.4.21.5) Prothrombin (EC 3.4.21.5) (Coagulation factor II) |
Synonyms | |
Description | FUNCTION: Thrombin, which cleaves bonds after Arg and Lys, converts fibrinogen to fibrin and activates factors V, VII, VIII, XIII, and, in complex with thrombomodulin, protein C. Functions in blood homeostasis, inflammation and wound healing. . FUNCTION: Thrombin, which cleaves bonds after Arg and Lys, converts fibrinogen to fibrin and activates factors V, VII, VIII, XIII, and, in complex with thrombomodulin, protein C. Functions in blood homeostasis, inflammation and wound healing. . FUNCTION: Plasmin dissolves the fibrin of blood clots and acts as a proteolytic factor in a variety of other processes including embryonic development, tissue remodeling, tumor invasion, and inflammation. In ovulation, weakens the walls of the Graafian follicle. It activates the urokinase-type plasminogen activator, collagenases and several complement zymogens, such as C1 and C5. Cleavage of fibronectin and laminin leads to cell detachment and apoptosis. Also cleaves fibrin, thrombospondin and von Willebrand factor. Its role in tissue remodeling and tumor invasion may be modulated by CSPG4. Binds to cells. . |
Accessions | ENST00000311907.10 C9JV37 Q86WA1 Q8TD58 ENST00000442468.1 ENST00000530231.5 A0A2P0ZHX7 Q15253 P00734 E9PIT3 |